The current study reports highly variable CYLD levels in both HMCLs and primary PC isolates from MM patients and correlates loss of CYLD, either by mutation or complete deletion of the locus, to MGUS progression and poor clinical prognosis in MM patients. Here, CYLD is linked to Miyoshi myopathy.